Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares (IINN)

RA'ANANA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the commencement of an AME technology implementation with a customer that is one of the world's 10 largest U.S.-based companies. This engagement marks a significant step in the practical execution of the Company's strategic expansion into advanced technology markets following its acquisition of the AME (Additive Manufactured Electronics) business, including Inspira's entry into the cryogenic connectivity space for quantum computing, where the AME platform is being leveraged to address one of the most critical scaling bottlenecks facing the quantum industry today.The rollout has already commenced and is focused on advancing Inspira's AME technology at a U.S. research and development facility, integrated into one of the world's most advanced corporate technology infrastructures. The customer operates at the forefront of artificial intelligence, computing infrastructure, and platform technologies globally.The Company believes this implementation process provides high-level validation of its AME platform and reflects ongoing commercial engagement with a customer operating at the highest tier of the global corporate technology landscape. Importantly, this engagement reinforces recurring revenue-generating activity associated with that customer relationship. Furthermore, the process demonstrates broader demand from elite technology organizations for solutions addressing next-generation hardware connectivity and integration challenges."We view this type of engagement as confirmation of the practical relevance of our AME platform," said Dagi Ben-Noon, Chief Executive Officer of Inspira. "We are not speaking about theoretical potential. We are engaged in an active implementation process with a paying customer ranked among the largest companies in the world, a company with the resources, expertise, and infrastructure to validate our AME technology at the highest level. We view this engagement as an important signal of where this platform can go."Inspira believes that the customer’s participation in this type of implementation process supports additional strategic opportunities and further strengthens the positioning of its AME platform across advanced technology markets.

RA'ANANA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”) today announced its entry into the quantum computing sector, targeting a critical connectivity bottleneck by directing its recently acquired additive manufactured electronics (“AME”) platform toward a new 3D architecture for systems operating in dilution cryostats.

Analyst Buy Rating for Inspira Technologies (NASDAQ: IINN)* Driven by Revolutionary Respiratory Technology, FDA-Cleared System Already Treating Patients, and $19 Billion Market Disruption Potential

Market News Alerts Reports: Inspira Technologies (NASDAQ: IINN)* is reported beginning deployment of its FDA-cleared INSPIRA ART100 system at a leading New York cardiothoracic program ranked among the top 15% nationally, marking a significant commercialization milestone in a sector experiencing unprecedented M&A activity. The medtech industry saw multiple billion-dollar acquisitions in 2024, including Johnson & Johnson's $13.1 billion acquisition of Shockwave Medical, Edwards' $4.2 billion sale of its Critical Care business to BD, and Boston Scientific's $3.7 billion Axonics purchase.

PESG Research releases an update following Inspira Technologies' (NASDAQ: IINN)* recent strategic developments and clinical achievements: Inspira has emerged as a potential disruptive force in respiratory care with its integrated technology approach. The company's recent clinical studies demonstrating 96% accuracy for its AI-powered HYLA blood sensor represent a significant technological validation as it targets multiple high-value healthcare segments.

PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) has reported exceptional clinical study outcomes for its HYLA blood sensor, with 96% accuracy achieved in a key parameter compared to traditional blood analyzers. This milestone achievement validates the company's AI-powered continuous blood monitoring technology and accelerates its path toward commercial deployment in multiple healthcare settings.

Future Markets Research Releases an update following recent developments: Inspira Technologies* (NASDAQ: IINN) has announced a significant advancement in its AI-driven medical platform with the integration of a next-generation oxygenation indicator into its HYLA blood sensor technology. This enhancement enables rapid detection of critical oxygen-related conditions without requiring intermittent blood draws, representing a potential breakthrough in continuous patient monitoring.

ORLANDO, FL / ACCESSWIRE / May 5, 2023 / RedChip Companies will air new interviews with Inspira Technologies OXY B.H.N. Ltd. (Nasdaq:IINN, IINNW) and Genius Group Limited (NYSE American:GNS) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 6, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

RA'ANANA, ISRAEL / ACCESSWIRE / April 24, 2023 / Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)(NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced today that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the 2023 Planet MicroCap Showcase in Las Vegas this week on Wednesday at 14:30 CST, April 26, 2023.

ORLANDO, FL / ACCESSWIRE / December 22, 2022 / RedChip Companies will air a new interview with Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, on The RedChip Money Report® on Bloomberg TV, this Saturday, December 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

ORLANDO, FL / ACCESSWIRE / October 21, 2022 / RedChip Companies will air a new interview with Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)(NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, on The RedChip Money Report® on Bloomberg TV, this Saturday, October 22, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

ORLANDO, FL / ACCESSWIRE / June 30, 2022 / RedChip Companies will air a new C-Level interview with Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologies") on The RedChip Money Report® on Bloomberg TV, this Saturday, July 2, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

NEW YORK, NY / ACCESSWIRE / July 19, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $16.0 Million Initial Public Offering of Common Units for Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN, IINNW) About Inspira Technologies OXY B.H.N. Ltd. Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology, which immediately